Fortin A - Search Results

1

Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.

Sonzogni-Desautels K, Renteria AE, Camargo FV, Di Lenardo TZ, Mikhail A, Arrowood MJ, Fortin A, Ndao M. Sonzogni-Desautels K, et al. Among authors: fortin a. Front Microbiol. 2015 Sep 23;6:973. doi: 10.3389/fmicb.2015.00973. eCollection 2015. Front Microbiol. 2015. PMID: 26441906 Free PMC article.

2

Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.

Wiltshire SA, Diez E, Miao Q, Dubé MP, Gagné M, Paquette O, Lafrenière RG, Ndao M, Castellani LW, Skamene E, Vidal SM, Fortin A. Wiltshire SA, et al. Among authors: fortin a. Physiol Genomics. 2012 Sep 1;44(17):843-52. doi: 10.1152/physiolgenomics.00025.2012. Epub 2012 Jul 17. Physiol Genomics. 2012. PMID: 22805347 Free PMC article.

3

Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.

Fortin A, Hendrickx S, Yardley V, Cos P, Jansen H, Maes L. Fortin A, et al. J Antimicrob Chemother. 2012 Nov;67(11):2707-12. doi: 10.1093/jac/dks273. Epub 2012 Jul 10. J Antimicrob Chemother. 2012. PMID: 22782488

4

Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.

Fortin A, Caridha DP, Leed S, Ngundam F, Sena J, Bosschaerts T, Parriott S, Hickman MR, Hudson TH, Grogl M. Fortin A, et al. PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3144. doi: 10.1371/journal.pntd.0003144. eCollection 2014 Sep. PLoS Negl Trop Dis. 2014. PMID: 25210745 Free PMC article.

5

Pharmacokinetics and pharmacodynamics of oleylphosphocholine in a hamster model of visceral leishmaniasis.

Fortin A, Dorlo TP, Hendrickx S, Maes L. Fortin A, et al. J Antimicrob Chemother. 2016 Jul;71(7):1892-8. doi: 10.1093/jac/dkw089. Epub 2016 Apr 15. J Antimicrob Chemother. 2016. PMID: 27084920

6

Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.

Paulussen C, Boulet G, Bosschaerts T, Cos P, Fortin A, Maes L. Paulussen C, et al. Among authors: fortin a. Mycoses. 2015 Mar;58(3):127-32. doi: 10.1111/myc.12286. Epub 2015 Jan 15. Mycoses. 2015. PMID: 25590577

7

Drug delivery by tattooing to treat cutaneous leishmaniasis.

Shio MT, Paquet M, Martel C, Bosschaerts T, Stienstra S, Olivier M, Fortin A. Shio MT, et al. Among authors: fortin a. Sci Rep. 2014 Feb 24;4:4156. doi: 10.1038/srep04156. Sci Rep. 2014. PMID: 24561704 Free PMC article.

8

Genetic control of host-pathogen interactions in mice.

Min-Oo G, Stevenson MM, Fortin A, Gros P. Min-Oo G, et al. Among authors: fortin a. Novartis Found Symp. 2007;281:156-65; discussion 165-8, 208-9. doi: 10.1002/9780470062128.ch13. Novartis Found Symp. 2007. PMID: 17534072 Review.

9

The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes.

Fortin A, Diez E, Henderson JE, Mogil JS, Gros P, Skamene E. Fortin A, et al. Novartis Found Symp. 2007;281:141-53; discussion 153-5, 208-9. doi: 10.1002/9780470062128.ch12. Novartis Found Symp. 2007. PMID: 17534071 Review.

10

Mapping cis-acting regulatory variation in recombinant congenic strains.

Lee PD, Ge B, Greenwood CM, Sinnett D, Fortin Y, Brunet S, Fortin A, Takane M, Skamene E, Pastinen T, Hallett M, Hudson TJ, Sladek R. Lee PD, et al. Among authors: fortin y, fortin a. Physiol Genomics. 2006 Apr 13;25(2):294-302. doi: 10.1152/physiolgenomics.00168.2005. Epub 2006 Jan 31. Physiol Genomics. 2006. PMID: 16449383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page